FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine, namely to neurology, and concerns treating chronic pain. That is ensured by 99.9 % subcutaneous injection of medical xenon, sufficient amount of xenon for analgesia.
EFFECT: it provides effective and prolonged analgesia in chronic pain without side effects and neurotoxic action, which, in turn, enables using the given method in patients with accompanying diseases.
4 cl, 3 tbl, 2 ex, 6 dwg
Authors
Dates
2020-07-08—Published
2019-11-11—Filed